Pharmacists in Lutherville Timonium, MD Accepting Medicare

2 Pharmacists found. Showing 1 - 2

Ruth-ann Camille Christie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 York Rd, Lutherville Timonium, MD 21093 Phone: 443-470-4050

Dr. Matthew Borrison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17 E Padonia Rd, Lutherville Timonium, MD 21093 Phone: 443-330-5987

News Archive

K2M enters French spinal device market with MESA Deformity Spinal System

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced at the Scoliosis Research Society's 48th Annual Conference in Lyon, France, that it has entered the spinal device market in France.

Physicians assistants, nurse practitioners take on more primary care duties

In the final part of a three-part series on primary care, NPR reports on physicians assistants and nurse practitioners taking the place of physicians as deliverers of primary care. "Unlike physicians in primary care, the number of physician assistants and nurse practitioners are on the rise. According to the American Academy of Physician Assistants, there were 74,100 physician assistants in practice in 2008, the most recent census available.

"Doctor shopping" results in increased drug use among postoperative orthopaedic trauma patients

"Doctor shopping," the growing practice of obtaining narcotic prescriptions from multiple providers, has led to measurable increases in drug use among postoperative orthopaedic trauma patients, according to a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

Ingenol mebutate drug does not offer added benefit over diclofenac/hyaluronic acid gel

The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.

Read more Medical News

› Verified 7 days ago